Oncotartis, Inc.
Get Full AccessDescription
- OncoTartis, Inc. is a private biotechnology company established in 2011. It is located at the Thomas R. Beecher Innovation Center on Buffalo Niagara Medical Campus. It has a strategic partnership with Roswell Park Cancer Institute where the original intellectual property was developed in the laboratory of Professor Andrei Gudkov.Mission: to revolutionize treatment of a subset of cancers (breast, prostate, ovarian, melanoma and hematological malignancies) by developing a novel category of anti-cancer drugs directed against tissue- specific targets.Technology: OncoTartis is exploring a proprietary drug discovery approach called TARTIS (TARTIS = TARgeting TISsue). TARTIS is designed to develop small molecules for treatment of malignancies originating from specific tissues that are either non-essential for the general viability of mammalian organism (i.e., gender-associated tissues or melanocytes) or can be effectively replaced (hematopoietic system).Leading candidate: An anti-AML candidate, OT-82, has a favorable set of structural, ADME and toxicological properties. A broad composition of matter patent application was filed in 2013. OT-82 is an NAMPT (NicotinAMide Phosphoribosyl Transferase) inhibitor. A remarkably broad spectrum of NAMPT functions positions OT-82 as a drug candidate for treatment of other NAMPT-dependent cancers, inflammatory diseases and disorders associated with deregulated circadian clock.
-
Headquarters:640 Ellicott Street Suite 480, Buffalo, New York, United States
More -
Phone Number: +1 617-460-9662
-
Website: https://www.oncotartis.com
-
Employees:5
-
Revenue:$1 - 10M
-
Legal Name:Oncotartis, Inc.
-
Oncotartis, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Oncotartis, Inc.
-
Where are Oncotartis, Inc.'s Headquarters?
Oncotartis, Inc.'s Headquarters are in 640 Ellicott Street Suite 480,Buffalo,New York,United States
-
What is Oncotartis, Inc.'s phone number?
Oncotartis, Inc.'s phone number is +1 617-460-9662
-
What is Oncotartis, Inc.'s official website?
Oncotartis, Inc.'s official website is https://www.oncotartis.com
-
What is Oncotartis, Inc.'s Revenue?
Oncotartis, Inc.'s revenue is $1 - 10M
-
What is Oncotartis, Inc.'s NAICS code?
Oncotartis, Inc.'s NAICS code is 541713
-
How many employees are working in Oncotartis, Inc.
Oncotartis, Inc. has 5 employees
-
What is Oncotartis, Inc.'s Industry?
Oncotartis, Inc. is in the industry of Biotechnology
-
Who is Oncotartis, Inc.'s Vice President Research And Development?
Oncotartis, Inc.'s Vice President Research And Development is Olga Chernova